>>187544, >>187545, >>187546, >>187547, >>187548, >>187549, >>187550, >>187551, >>187552, >>187553, >>187554, >>187555, >>187556, >>187557, >>187558, >>187559, >>187560, >>187561, >>187562, >>187563, >>187564, >>187565, >>187566, >>187567, >>187568, >>187569, >>187570, >>187571, >>187572, >>187573, >>187574, >>187575, >>187576, >>187577, >>187578, >>187579, >>187580, >>187581, >>187582, >>187583, >>187584, >>187585, >>187586, >>187587, >>187588, >>187589, >>187590, >>187591, >>187592, >>187593, >>187594, >>187595, >>187596, >>187597, >>187598, >>187599, >>187600, >>187601, >>187602, >>187603, >>187604, >>187605, >>187606, >>187607, >>187608, >>187609, >>187610, >>187611, >>187612, >>187613
The Vigilant Fox @VigilantFox - Video: The broader implications are the most disturbing of all.
If the material is bloodborne and systemic, risk becomes the central concern. For funeral professionals, direct handling remains the most immediate issue, making standard precautions—gloves, masks, and proper sterilization—essential.
Beyond that, the uncertainty remains. There is no established evidence proving casual contagiousness. There is also no clear evidence proving how, whether, or under what conditions this material could be passed between people. Because the issue involves blood and possibly bodily fluids, critics warn that blood contact, sexual intimacy, transfusion safety, and pregnancy-related questions deserve serious investigation rather than casual reassurance.
Pregnancy-related concerns are especially sensitive. Reports involving fetal loss and clotting abnormalities in infants have been raised, not as proof, but as signals that demand urgent study—particularly given existing research into spike protein and placental health.
Then there are the long-term disease implications.
Amyloid-like structures are linked to conditions such as Alzheimer’s, Parkinson’s, and other degenerative diseases. This does not establish causation, but if misfolded proteins are circulating in the bloodstream, the concern cannot be ignored.
The vascular implications are just as serious. Abnormal clotting in major organs could relate to outcomes like stroke, heart attack, or pulmonary embolism. While causation remains unproven, reported overlaps with clotting-related data raise important questions.
There is also evidence suggesting some of these structures may form before death, including observations consistent with blood flow-related clotting patterns. If confirmed, the implications would be significant.
Ultimately, the issue returns to institutional response. Why have major health agencies, research institutions, and blood banks not conducted large-scale, independent testing?
The demand is simple: collect samples, run rigorous analyses, publish the findings, and provide clear answers.
Calls for formal hearings reflect growing frustration. Senator Ron Johnson has already held hearings on COVID vaccine injuries, myocarditis, and cancer concerns. A hearing on white fibrous clots would force the issue into the open.
Key questions remain unanswered:
• What are these structures?
• How common are they?
• Do they form before death?
• Are they linked to infection, injection, spike protein exposure, or something else?